A new MRI approach could spare patients unnecessary lung biopsies

NCT ID NCT07768046

First seen Aug 17, 2026 ยท Last updated Aug 17, 2026

Summary

This study explores whether a special MRI scan, done without any contrast dye, can tell the difference between benign and cancerous lung nodules that were flagged as suspicious on a routine lung cancer screening CT. Adults aged 50 to 80 with a history of heavy smoking and a Lung-RADS 4 nodule will receive one additional MRI scan. The MRI results will be compared with the final diagnosis from biopsy or long-term follow-up to see how accurate the scan is.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Multiparametric chest MRI with diffusion-weighted imaging (no contrast)
What this could lead to
If successful, this could offer a safer, contrast-free imaging method to help doctors decide which lung nodules need biopsy, reducing unnecessary invasive procedures.
What could go wrong
This is a small pilot study with only 30 participants, so results may not be definitive. The MRI might not reliably distinguish all benign from malignant nodules, and its accuracy needs confirmation in larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER SCREENING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung neoplasm Multiple Pulmonary Nodules pulmonary coin lesion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UF Health Shands Hospital

    Gainesville, Florida, 32610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.